Compass Therapeutics, Inc.
CMPX • NASDAQ • Stock Fundamentals
Compass Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Thomas J. Schuetz, with a market cap of $362.0M.
Market Cap$362.0M
Employees32.0
CEOThomas J. Schuetz
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026
View reportNext EarningsAug 10, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Compass Therapeutics, Inc. FAQ
Common questions about Compass Therapeutics, Inc.
Compass Therapeutics, Inc. (CMPX) has a market capitalization of $362.0M and trades on NASDAQ.
Compass Therapeutics, Inc. has approximately 32 employees.